BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russo MW, Galanko J, Beavers K, Fried MW, Shrestha R. Patient and graft survival in hepatitis C recipients after adult living donor liver transplantation in the United States: Living Donor Liver Transplant and Hepatitis C. Liver Transpl 2004;10:340-6. [DOI: 10.1002/lt.20090] [Cited by in Crossref: 86] [Cited by in F6Publishing: 75] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Abbasoglu O. Liver transplantation: Yesterday, today and tomorrow. World J Gastroenterol 2008; 14(20): 3117-3122 [PMID: 18506914 DOI: 10.3748/wjg.14.3117] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
2 Selzner N, Girgrah N, Lilly L, Guindi M, Selzner M, Therapondos G, Adeyi O, McGilvray I, Cattral M, Greig PD. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age. Liver Transpl. 2008;14:1778-1786. [PMID: 19025914 DOI: 10.1002/lt.21598] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
3 He C, Liu X, Peng W, Li C, Wen TF. Evaluation the efficacy and safety of simultaneous splenectomy in liver transplantation patients: A meta-analysis. Medicine (Baltimore) 2018;97:e0087. [PMID: 29517676 DOI: 10.1097/MD.0000000000010087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
4 Schmeding M, Neumann UP, Puhl G, Bahra M, Neuhaus R, Neuhaus P. Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. Liver Transpl. 2007;13:687-692. [PMID: 17457911 DOI: 10.1002/lt.21138] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
5 Garcia-retortillo M, Forns X, Llovet JM, Navasa M, Feliu A, Massaguer A, Bruguera M, Fuster J, Garcia-valdecasas JC, Rimola A. Hepatitis C recurrence is more severe after living donor compared to cadaveric liver transplantation. Hepatology 2004;40:699-707. [DOI: 10.1002/hep.20357] [Cited by in Crossref: 157] [Cited by in F6Publishing: 129] [Article Influence: 9.2] [Reference Citation Analysis]
6 Akamatsu N, Sugawara Y, Kokudo N, Eguchi S, Fujiwara T, Ohdan H, Nagano H, Taketomi A, Kitagawa Y, Shimada M. Outcomes of living donor liver transplantation for hepatitis C virus-positive recipients in Japan: results of a nationwide survey. Transpl Int. 2014;27:767-774. [PMID: 24684710 DOI: 10.1111/tri.12329] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
7 Kuo A, Terrault NA. Management of Hepatitis C in Liver Transplant Recipients: Management of Hepatitis C in Liver Transplant Recipients. American Journal of Transplantation 2006;6:449-58. [DOI: 10.1111/j.1600-6143.2005.01202.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
8 Jin SG, Xiang B, Yan LN, Chen ZY, Yang JY, Xu MQ, Wang WT. Quality of life and psychological outcome of donors after living donor liver transplantation. World J Gastroenterol 2012; 18(2): 182-187 [PMID: 22253525 DOI: 10.3748/wjg.v18.i2.182] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
9 Teixeira R, Godinho Menezes É, Schiano TD. Therapeutic management of recurrent hepatitis C after liver transplantation. Liver Int 2007;27:302-12. [DOI: 10.1111/j.1478-3231.2006.01426.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
10 Terrault NA, Stravitz RT, Lok AS, Everson GT, Brown RS, Kulik LM, Olthoff KM, Saab S, Adeyi O, Argo CK. Hepatitis C disease severity in living versus deceased donor liver transplant recipients: an extended observation study. Hepatology. 2014;59:1311-1319. [PMID: 24677192 DOI: 10.1002/hep.26920] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
11 Liu LU, Schiano TD. Adult Live Donor Liver Transplantation. Clinics in Liver Disease 2005;9:767-86. [DOI: 10.1016/j.cld.2005.08.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
12 Berenguer M. Hepatitis C after liver transplantation: risk factors, outcomes, and treatment: . Current Opinion in Organ Transplantation 2005;10:81-9. [DOI: 10.1097/01.mot.0000161761.40866.12] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
13 Watt KD, Burak K, Deschênes M, Lilly L, Marleau D, Marotta P, Mason A, Peltekian KM, Renner EL, Yoshida EM; Canadian Transplant Hepatology Outcomes Research Network. Recurrent hepatitis C post-transplantation: where are we now and where do we go from here? A report from the Canadian transplant hepatology workshop. Can J Gastroenterol 2006;20:725-34. [PMID: 17111055 DOI: 10.1155/2006/238218] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
14 Akamatsu N, Sugawara Y. Living-donor liver transplantation and hepatitis C. HPB Surg 2013;2013:985972. [PMID: 23401640 DOI: 10.1155/2013/985972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
15 Levitsky J, Doucette K; the AST Infectious Diseases Community of Practice. Viral Hepatitis in Solid Organ Transplant Recipients. American Journal of Transplantation 2009;9:S116-30. [DOI: 10.1111/j.1600-6143.2009.02902.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
16 Brown KA. Liver transplantation. Curr Opin Gastroenterol 2005;21:331-6. [PMID: 15818154 DOI: 10.1097/01.mog.0000159830.36793.2b] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
17 Fink SA, Brown RS. Liver Transplantation: Indications, Preoperative Evaluation and Posttransplantation Management. Clinical Hepatology. Berlin: Springer Berlin Heidelberg; 2010. pp. 1353-81. [DOI: 10.1007/978-3-642-04519-6_49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Brown RS. Hepatitis C and liver transplantation. Nature. 2005;436:973-978. [PMID: 16107838 DOI: 10.1038/nature04083] [Cited by in Crossref: 261] [Cited by in F6Publishing: 235] [Article Influence: 16.3] [Reference Citation Analysis]
19 Miyaaki H, Ichikawa T, Taura N, Miuma S, Honda T, Shibata H, Soyama A, Hidaka M, Takatsuki M, Eguchi S, Nakao K. Impact of Donor and Recipient Single Nucleotide Polymorphisms in Living Liver Donor Transplantation for Hepatitis C. Transplant Proc 2015;47:2916-9. [PMID: 26707313 DOI: 10.1016/j.transproceed.2015.10.044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
20 Cameron AM, Ghobrial RM, Hiatt JR, Carmody IC, Gordon SA, Farmer DG, Yersiz H, Zimmerman MA, Durazo F, Han SH, Saab S, Gornbein J, Busuttil RW. Effect of nonviral factors on hepatitis C recurrence after liver transplantation. Ann Surg 2006;244:563-71. [PMID: 16998365 DOI: 10.1097/01.sla.0000237648.90600.e9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.2] [Reference Citation Analysis]
21 Dhanasekaran R, Firpi RJ. Challenges of recurrent hepatitis C in the liver transplant patient. World J Gastroenterol 2014; 20(13): 3391-3400 [PMID: 24707122 DOI: 10.3748/wjg.v20.i13.3391] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
22 Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl. 2006;12:560-565. [PMID: 16555313 DOI: 10.1002/lt.20660] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 2.9] [Reference Citation Analysis]
23 Brown RS Jr. Is recurrence of hepatitis C worse after living donor or deceased donor liver transplantation? Liver Transpl 2004;10:1256-7. [PMID: 15376336 DOI: 10.1002/lt.20284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Northup PG, Abecassis MM, Englesbe MJ, Emond JC, Lee VD, Stukenborg GJ, Tong L, Berg CL; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group. Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl 2009;15:148-62. [PMID: 19177435 DOI: 10.1002/lt.21671] [Cited by in Crossref: 34] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
25 Schiano TD, Gutierrez JA, Walewski JL, Fiel MI, Cheng B, Bodenheimer H, Thung SN, Chung RT, Schwartz ME, Bodian C, Branch AD. Accelerated hepatitis C virus kinetics but similar survival rates in recipients of liver grafts from living versus deceased donors. Hepatology 2005;42:1420-8. [DOI: 10.1002/hep.20947] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 2.6] [Reference Citation Analysis]
26 Biggins SW, Terrault NA. Management of Recurrent Hepatitis C in Liver Transplant Recipients. Infectious Disease Clinics of North America 2006;20:155-74. [DOI: 10.1016/j.idc.2006.01.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
27 Takada Y, Haga H, Ito T, Nabeshima M, Ogawa K, Kasahara M, Oike F, Ueda M, Egawa H, Tanaka K. Clinical Outcomes of Living Donor Liver Transplantation for Hepatitis C Virus (HCV)-Positive Patients: . Transplantation 2006;81:350-4. [DOI: 10.1097/01.tp.0000197554.16093.d1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
28 Udell IW, Barshes NR, Finegold MJ, Lee TC, Scott JD, Carter B, Karpen S, Goss JA. Hepatitis C viral recurrence in a pediatric patient following liver transplantation. Pediatric Transplantation 2006;10:617-22. [DOI: 10.1111/j.1399-3046.2006.00519.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
29 Tamura S, Sugawara Y. Treatment strategy for hepatitis C after liver transplantation. J Hepatobiliary Pancreat Surg 2008;15:111-23. [DOI: 10.1007/s00534-007-1295-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
30 Tamura S, Sugawara Y, Yamashiki N, Kaneko J, Kokudo N, Makuuchi M. Pre-emptive antiviral therapy in living donor liver transplantation for hepatitis C: observation based on a single-center experience. Transpl Int. 2010;23:580-588. [PMID: 20028490 DOI: 10.1111/j.1432-2277.2009.01023.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
31 Akamatsu N, Sugawara Y. Liver transplantation and hepatitis C. Int J Hepatol 2012;2012:686135. [PMID: 22900194 DOI: 10.1155/2012/686135] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
32 Brown RS. Live donors in liver transplantation. Gastroenterology. 2008;134:1802-1813. [PMID: 18471556 DOI: 10.1053/j.gastro.2008.02.092] [Cited by in Crossref: 132] [Cited by in F6Publishing: 99] [Article Influence: 10.2] [Reference Citation Analysis]
33 Kuo A, Terrault NA. Is recurrent hepatitis C worse with living donors? Current Opinion in Organ Transplantation 2009;14:240-4. [DOI: 10.1097/mot.0b013e32832b1f1d] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
34 Lengyel G, Tulassay Z. [Treatment of recurrent hepatitis C virus infection after liver transplantation]. Orv Hetil 2007;148:1875-81. [PMID: 17905682 DOI: 10.1556/OH.2007.28217] [Reference Citation Analysis]
35 Coelho JC, Okawa L, Parolin MB, Freitas AC, Matias JE, Matioski AR. [Hepatitis C recurrence after living donor and cadaveric liver transplantation]. Arq Gastroenterol. 2009;46:38-42. [PMID: 19466308 DOI: 10.1590/s0004-28032009000100012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
36 Schiano TD, Martin P. Management of HCV infection and liver transplantation. Int J Med Sci 2006;3:79-83. [PMID: 16614748 DOI: 10.7150/ijms.3.79] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
37 Sugawara Y, Makuuchi M, Matsui Y, Kishi Y, Akamatsu N, Kaneko J, Kokudo N. Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation. 2004;78:1308-1311. [PMID: 15548968 DOI: 10.1097/01.tp.0000142677.12473.e5] [Cited by in Crossref: 100] [Cited by in F6Publishing: 21] [Article Influence: 5.9] [Reference Citation Analysis]
38 Killackey MT, Gondolesi GE, Liu LU, Paramesh AS, Thung SN, Suriawinata A, Nguyen E, Roayaie S, Schwartz ME, Emre S. Effect of ischemia-reperfusion on the incidence of acute cellular rejection and timing of histologic hepatitis C virus recurrence after liver transplantation. Transplant Proc. 2008;40:1504-1510. [PMID: 18589139 DOI: 10.1016/j.transproceed.2008.03.101] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
39 Forman LM, Trotter JF, Emond J. Living donor liver transplantation and hepatitis C. Liver Transpl. 2004;10:347-348. [PMID: 15004759 DOI: 10.1002/lt.20091] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
40 Gridelli B, Panarello G, Gruttadauria S, Marcos A, Grossi P. Infections after Living-Donor Liver Transplantation. Surgical Infections 2006;7:s-105-8. [DOI: 10.1089/sur.2006.7.s2-105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
41 Liu CL, Fan ST. Adult-to-adult live-donor liver transplantation: the current status. J Hepatobiliary Pancreat Surg. 2006;13:110-116. [PMID: 16547671 DOI: 10.1007/s00534-005-1016-x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.3] [Reference Citation Analysis]
42 Levitsky J, Doucette K; the AST Infectious Diseases Community of Practice. Viral Hepatitis in Solid Organ Transplantation: Viral Hepatitis. American Journal of Transplantation 2013;13:147-68. [DOI: 10.1111/ajt.12108] [Cited by in Crossref: 56] [Cited by in F6Publishing: 46] [Article Influence: 7.0] [Reference Citation Analysis]
43 Berenguer M. Live donor liver transplantation for hepatitis C: New data, old story. Liver Transpl 2006;12:516-9. [DOI: 10.1002/lt.20656] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
44 Sugawara Y, Makuuchi M. Should living donor liver transplantation be offered to patients with hepatitis C virus cirrhosis? Journal of Hepatology 2005;42:472-5. [DOI: 10.1016/j.jhep.2005.01.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
45 Renz JF, Kin CJ, Saggi BH, Emond JC. Outcomes of Living Donor Liver Transplantation. Transplantation of the Liver. Elsevier; 2005. pp. 713-24. [DOI: 10.1016/b978-0-7216-0118-2.50052-5] [Cited by in Crossref: 10] [Article Influence: 0.6] [Reference Citation Analysis]
46 Verna EC, Brown RS. Hepatitis C Virus and Liver Transplantation. Clinics in Liver Disease 2006;10:919-40. [DOI: 10.1016/j.cld.2006.08.012] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 5.0] [Reference Citation Analysis]
47 Roche B, Samuel D. Aspects of hepatitis C virus infection relating to liver transplantation: . European Journal of Gastroenterology & Hepatology 2006;18:313-20. [DOI: 10.1097/00042737-200604000-00002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
48 Tang W, Qiu JG, Cai Y, Cheng L, Du CY. Increased Surgical Complications but Improved Overall Survival with Adult Living Donor Compared to Deceased Donor Liver Transplantation: A Systematic Review and Meta-Analysis. Biomed Res Int 2020;2020:1320830. [PMID: 32908865 DOI: 10.1155/2020/1320830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
49 Kaibori M, Ha-Kawa SK, Uchida Y, Ishizaki M, Hijikawa T, Saito T, Imamura A, Hirohara J, Uemura Y, Tanaka K. Recurrent hepatitis C after living donor liver transplantation detected by Tc-99m GSA liver scintigraphy. Dig Dis Sci. 2006;51:2013-2017. [PMID: 16977504 DOI: 10.1007/s10620-006-9534-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
50 Fisher RA, Cotterell AH, Maluf DG, Todd Stravitz R, Ashworth A, Nakatsuka M, Sterling RK, Luketic VA, Behnke MK, Posner MP. Adult living donor versus deceased donor liver transplantation: A 10-year prospective single center experience. Annals of Hepatology 2009;8:298-307. [DOI: 10.1016/s1665-2681(19)31742-9] [Cited by in Crossref: 26] [Article Influence: 2.2] [Reference Citation Analysis]
51 Verna EC, Brown RS. Hepatitis C and Liver Transplantation: Enhancing Outcomes and Should Patients Be Retransplanted. Clinics in Liver Disease 2008;12:637-59. [DOI: 10.1016/j.cld.2008.03.010] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
52 Fink SA, Brown RS. Current Indications, Contraindications, Delisting Criteria, and Timing for Liver Transplantation. Transplantation of the Liver. Elsevier; 2005. pp. 95-114. [DOI: 10.1016/b978-0-7216-0118-2.50012-4] [Cited by in Crossref: 3] [Article Influence: 0.2] [Reference Citation Analysis]
53 Park JI, Choi KM, Lee SG, Hwang S, Kim KH, Ahn CS, Moon DB, Chung YH, Lee YS, Suh DJ. [Clinical outcome after living donor liver transplantation in patients with hepatitis C virus-associated cirrhosis]. Korean J Hepatol 2007;13:543-55. [PMID: 18159152 DOI: 10.3350/kjhep.2007.13.4.543] [Cited by in Crossref: 4] [Article Influence: 0.3] [Reference Citation Analysis]
54 Friman S. Recurrence of hepatitis C after liver transplantation. Transplant Proc 2005;37:3311-2. [PMID: 16298582 DOI: 10.1016/j.transproceed.2005.09.033] [Reference Citation Analysis]
55 Russo MW, Shrestha R. Is severe recurrent hepatitis C more common after adult living donor liver transplantation. Hepatology. 2004;40:524-526. [PMID: 15349889 DOI: 10.1002/hep.20418] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
56 Taki-Eldin A, Zhou L, Xie HY, Zheng SS. Liver regeneration after liver transplantation. Eur Surg Res. 2012;48:139-153. [PMID: 22572792 DOI: 10.1159/000337865] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
57 Chan SC, Liu CL, Lo CM, Lam BK, Lee EW, Fan ST. Donor quality of life before and after adult-to-adult right liver live donor liver transplantation. Liver Transpl. 2006;12:1529-1536. [PMID: 17004265 DOI: 10.1002/lt.20897] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
58 Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS. Comparative Analysis of Hepatitis C Recurrence and Fibrosis Progression Between Deceased-Donor and Living-Donor Liver Transplantation: 8-Year Longitudinal Follow-Up. Transplantation 2011;92:453-60. [DOI: 10.1097/tp.0b013e3182259282] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
59 Lei J, Yan L, Wang W. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy. Eur J Gastroenterol Hepatol. 2013;25:1340-1346. [PMID: 23652915 DOI: 10.1097/meg.0b013e3283622743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
60 Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis. Transplant Proc 2008;40:1481-4. [PMID: 18589133 DOI: 10.1016/j.transproceed.2008.03.085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
61 Olsen SK, Brown RS Jr. Live donor liver transplantation: current status. Curr Gastroenterol Rep 2008;10:36-42. [PMID: 18417041 DOI: 10.1007/s11894-008-0007-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
62 Hu A, Liang W, Zheng Z, Guo Z, He X. Living donor vs. deceased donor liver transplantation for patients with hepatitis C virus-related diseases. J Hepatol. 2012;57:1228-1243. [PMID: 22820490 DOI: 10.1016/j.jhep.2012.07.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
63 Carrión JA, Forns X. Living donor liver transplantation and hepatitis C: lessons from the learning curve? Liver Transpl. 2007;13:18-20. [PMID: 17192905 DOI: 10.1002/lt.20914] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Terrault NA, Shiffman ML, Lok AS, Saab S, Tong L, Brown RS, Everson GT, Reddy KR, Fair JH, Kulik LM. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007;13:122-129. [PMID: 17192908 DOI: 10.1002/lt.20995] [Cited by in Crossref: 100] [Cited by in F6Publishing: 70] [Article Influence: 7.1] [Reference Citation Analysis]
65 Limaye AR, Firpi RJ. Management of recurrent hepatitis C infection after liver transplantation. Clin Liver Dis 2011;15:845-58. [PMID: 22032532 DOI: 10.1016/j.cld.2011.08.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
66 Brown R, Emond JC. Managing Access to Liver Transplantation: Implications for Gastroenterology Practice. Gastroenterology 2007;132:1152-63. [DOI: 10.1053/j.gastro.2007.01.054] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
67 Foster R, Zimmerman M, Trotter JF. Expanding Donor Options: Marginal, Living, and Split Donors. Clinics in Liver Disease 2007;11:417-29. [DOI: 10.1016/j.cld.2007.04.004] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 3.2] [Reference Citation Analysis]
68 Sher L, Jennings L, Rudich S, Alexopoulos SP, Netto G, Teperman L, Kinkhabwala M, Brown RS, Pomfret E, Klintmalm G; HCV-3 Study Group. Results of live donor liver transplantation in patients with hepatitic C virus infection: the HCV 3 trial experience: Results of live donor liver transplant for HCV. Clin Transplant 2012;26:502-9. [DOI: 10.1111/j.1399-0012.2011.01561.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
69 Dunn W, O’Neil M, Zhao J, Wu CH, Roberts B, Chakraborty S, Sherman C, Weaver B, Taylor R, Olson J. Donor PNPLA3 rs738409 genotype affects fibrosis progression in liver transplantation for hepatitis C. Hepatology. 2014;59:453-460. [PMID: 24123231 DOI: 10.1002/hep.26758] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
70 Sugawara Y, Makuuchi M. Living donor liver transplantation to patients with hepatitis C virus cirrhosis. World J Gastroenterol 2006; 12(28): 4461-4465 [PMID: 16874855 DOI: 10.3748/wjg.v12.i28.4461] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
71 Masuzaki R, Yamashiki N, Sugawara Y, Yoshida H, Tateishi R, Tamura S, Kaneko J, Hasegawa K, Kokudo N, Makuuchi M, Omata M. Assessment of liver stiffness in patients after living donor liver transplantation by transient elastography. Scand J Gastroenterol 2009;44:1115-20. [PMID: 19562623 DOI: 10.1080/00365520903078810] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
72 Biggins SW, Terrault NA. Treatment of recurrent hepatitis C after liver transplantation. Clin Liver Dis. 2005;9:505-523, ix. [PMID: 16023980 DOI: 10.1016/j.cld.2005.05.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
73 Takada Y, Uemoto S. Living donor liver transplantation for hepatitis C. Surg Today. 2013;43:709-714. [PMID: 23052749 DOI: 10.1007/s00595-012-0361-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Kishi Y, Sugawara Y, Akamatsu N, Kaneko J, Tamura S, Kokudo N, Makuuchi M. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005;19:769-72. [PMID: 16313323 DOI: 10.1111/j.1399-0012.2005.00419.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
75 Alsatie M, Chalasani N, Kwo PY. Management of hepatitis C infection after liver transplantation. Drugs 2007;67:871-85. [PMID: 17428105 DOI: 10.2165/00003495-200767060-00004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]